The YKR078W antibody is a specialized reagent targeting the YKR078W protein in Saccharomyces cerevisiae (Baker’s yeast). This antibody is primarily utilized in molecular biology research to investigate protein localization, interaction networks, and functional roles in yeast endosomal trafficking.
YKR078W (Vin1) interacts with Vrl1 to mediate endosomal membrane remodeling. Key discoveries include:
Localization: Normally cytosolic, Vin1 relocalizes to punctate endosomal structures upon Vrl1 co-expression .
Genetic Interaction: Deletion of VIN1 disrupts Vrl1 localization, indicating codependency .
Functional Redundancy: Unlike its paralog Vps5 (retromer subunit), Vin1 operates in a distinct trafficking pathway, suggesting diversification of SNX-BAR protein roles .
The YKR078W antibody has been employed to:
Validate protein expression in yeast lysates via Western blotting.
Study Vin1 subcellular localization using immunofluorescence .
Investigate interactions with Vrl1 through co-immunoprecipitation assays.
| Protein | Complex | Localization | Function |
|---|---|---|---|
| YKR078W (Vin1) | VINE complex | Cytosol / endosomal puncta | PI3P-dependent endosomal sorting |
| Vps5 | Retromer complex | Endosomes | Cargo retrieval to Golgi |
| Snx4 | Snx4-Atg20 | Endosomes | Autophagy-related trafficking |
While no direct validation data for the YKR078W antibody is provided in the search results, broader studies emphasize:
The necessity of knockout controls to confirm specificity, as highlighted by the YCharOS initiative .
Recombinant antibodies generally outperform polyclonal/monoclonal ones in reliability .
Functional Studies: Elucidate Vin1’s role in PI3P signaling and its contribution to fungal pathogenicity.
Structural Insights: Cryo-EM studies of the VINE complex could reveal mechanistic details of membrane remodeling.
YKR078W, also known as Vin1 (Vrl1-Interacting Sorting Nexin 1), is a cytoplasmic protein found in Saccharomyces cerevisiae. It functions as a component of the VINE complex and is a paralog of the membrane-binding retromer subunit Vps5 . Understanding the nomenclature is essential when searching literature and designing experiments, as some research papers may refer to it by either name. When selecting antibodies, ensure they are validated for the specific protein regardless of the nomenclature used.
YKR078W contains a Phox homology (PX) domain that specifically binds phosphatidylinositol 3-phosphate (PtdIns-3-P) . When selecting antibodies, researchers should consider whether the epitope corresponds to conserved regions of the PX domain or more unique regions of the protein. Antibodies targeting highly conserved domains may cross-react with related proteins like its paralog VPS5, potentially confounding experimental results. For highly specific detection, consider antibodies raised against unique regions outside the conserved PX domain.
Although YKR078W/Vin1 was initially reported to have a cytosolic distribution, more recent research indicates that when co-expressed with its interaction partner Vrl1, it localizes to punctate structures . This localization pattern is interdependent, as Vin1-Envy and Vrl1-Envy require the presence of their respective partners for localization to puncta . When using antibodies for immunofluorescence, researchers should expect different staining patterns depending on the expression level of Vrl1 in their experimental system. Controls that manipulate Vrl1 expression can help validate the specificity of YKR078W antibody staining patterns.
The gold standard for antibody validation is using knockout (KO) controls. For YKR078W antibodies, researchers should:
Create YKR078W knockout strains using CRISPR-Cas9 or similar gene editing techniques
Run parallel experiments with wild-type and knockout samples
Test antibody performance in multiple applications (Western blot, immunoprecipitation, immunofluorescence)
Verify specificity by observing signal elimination in knockout samples
This approach provides rigorous validation that the antibody recognizes the intended target . While this validation process requires significant time and resources, it eliminates the risk of false positives that can compromise research outcomes.
When studying YKR078W/Vin1 co-localization with other proteins, include the following controls:
Vrl1 knockout controls (since YKR078W/Vin1 localization depends on Vrl1)
Positive controls with known interaction partners
Secondary antibody-only controls to assess background staining
Blocking peptide controls to confirm epitope specificity
Multiple antibodies targeting different epitopes of YKR078W to confirm localization patterns
When interpreting Western blot results with YKR078W antibodies, researchers should:
Verify the expected molecular weight (compare to predicted size of YKR078W)
Consider that protein stability is dependent on Vrl1 expression (Vin1-3HA requires Vrl1 for stability)
Look for potential post-translational modifications that may alter the apparent molecular weight
Be aware that YKR078W has 2 PTM sites that could affect antibody recognition
Use knockout controls to confirm band specificity
Western blot optimization may require testing different lysis conditions since protein-protein interactions, particularly with Vrl1, significantly impact YKR078W stability and detection.
For researchers interested in developing custom antibodies against YKR078W, computational design platforms like RosettaAntibodyDesign (RAbD) offer promising approaches:
Use structural data of YKR078W/Vin1 (if available) as input for epitope selection
Apply cluster-based CDR constraints to sample diverse antibody sequences and structures
Implement design risk ratio and antigen risk ratio metrics to assess design quality
Validate computational designs experimentally through expression and binding assays
This approach has demonstrated success in improving antibody affinities 10-50 fold by replacing individual CDRs with new lengths and clusters . For YKR078W research requiring highly specific antibodies, computational design could overcome limitations of traditionally generated antibodies.
Cross-reactivity between YKR078W and VPS5 presents a significant challenge for antibody specificity. To address this:
Perform sequence alignment to identify unique regions in YKR078W not shared with VPS5
Design epitope-specific antibodies targeting non-conserved regions
Use dual validation with both VPS5 and YKR078W knockout controls
Consider competition assays with purified YKR078W and VPS5 proteins
Employ pre-adsorption techniques to remove antibodies recognizing common epitopes
Researchers should note that while YKR078W and VPS5 arose from whole genome duplication , their cellular functions have diverged, with VPS5 functioning as part of retromer and YKR078W/Vin1 as part of the VINE complex .
To study dynamic changes in the YKR078W interactome:
Use YKR078W antibodies for co-immunoprecipitation followed by mass spectrometry (IP-MS)
Compare interactomes under different stresses or growth conditions
Validate key interactions with reciprocal IPs using antibodies against putative partners
Apply proximity labeling techniques (BioID, APEX) with YKR078W as the bait
Consider the impact of Vrl1 expression levels on the stability and interactions of YKR078W
This approach can reveal condition-specific interactions beyond the 53 interactors currently identified , potentially uncovering new functions of the VINE complex.
Optimal sample preparation varies by application:
For Western blot:
Use detergent conditions that preserve PX domain structure
Consider native vs. denaturing conditions based on epitope accessibility
For Immunoprecipitation:
Use mild lysis buffers to preserve protein-protein interactions
Consider crosslinking for transient interactions
For Immunofluorescence:
Test both methanol and paraformaldehyde fixation methods
Optimize permeabilization conditions for PX domain accessibility
Consider co-staining with Vrl1 to validate localization patterns
Each application requires specific optimization to account for the unique properties of YKR078W and its interactions.
When addressing localization discrepancies:
Verify Vrl1 expression in your experimental system, as YKR078W localization is Vrl1-dependent
Test multiple fixation and permeabilization methods that may affect epitope accessibility
Consider dual-labeling approaches with different YKR078W antibodies targeting distinct epitopes
Use fluorescently tagged YKR078W constructs as comparative controls
Determine if experimental conditions affect the formation of the VINE complex
The reported cytosolic vs. punctate distribution discrepancy highlights the importance of understanding protein context when interpreting immunofluorescence results.
The discovery that YKR078W (Vin1) forms the VINE complex with Vrl1 opens several research avenues:
Use YKR078W antibodies in combination with Vrl1 antibodies for co-localization studies
Apply proximity labeling techniques to identify additional VINE complex components
Develop structure-function studies using domain-specific antibodies
Investigate the endosomal tubule occupancy of the VINE complex using super-resolution microscopy
Study the redistribution of mannose 6-phosphate receptor-like proteins from endosomes by the VINE complex
These approaches can help elucidate the biological role of this recently characterized complex in endosomal trafficking.
When extending YKR078W research to different systems:
Perform sequence homology analysis to identify orthologs in other species
Test cross-reactivity of existing antibodies against orthologs
Consider epitope conservation when selecting antibodies for cross-species application
Validate antibody specificity in each new system using knockout controls
Be aware that protein-protein interactions, particularly with Vrl1 homologs, may differ between species
This is particularly important when translating findings from S. cerevisiae to pathogenic yeasts or more complex eukaryotic systems where sorting nexin proteins play conserved but adapted roles.